AR and Patent ductus arteriosus: ,10 The adenocarcinoma NOS is a diagnosis of exclusion and is differentiated from PDA by the positive immunohistochemical expression of the latter by androgen receptor (AR) and gross cystic disease fluid protein 15 (GCDFP-15).3